TherapeuticsMD reported $234K in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Cipla INR 39.1B 2.54B Mar/2026
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 63.8M 63.56M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Grifols EUR 766.49M 39.74M Dec/2024
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Pfizer USD 11.04B 1.24B Mar/2026
TherapeuticsMD USD 234K 79K Jun/2024